Century Therapeutics, Inc.(IPSC)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
IPSC has no upcoming report date in the calendar yet. It last reported on Nov 12, 2026; companies usually report every three months.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±6.0%).
Did the stock rise after good news?
The next-day move after each of its last 8 EPS beats and 2 misses.
In plain words: it beat expectations 8 times, but the stock still fell 5 of those 8 times.
- Aug '26Beat▼ -4.9%
- May '26Beat▼ -0.4%
- Mar '26Beat▼ -8.4%
- Nov '25Beat▼ -17.4%
- Aug '25Missed▲ +2.2%
- May '25Beat▲ +8.3%
- Mar '25Missed▼ -5.7%
- Nov '24Beat▲ +5.6%
- Aug '24Beat▲ +4.0%
- Mar '24Beat▼ -7.2%
Clear beats and misses with a known reaction only. What counts as a beat
Why did IPSC fall after beating earnings?
6 of IPSC's last 10 reactions went against the EPS result. What stands out in each:
IPSC beat EPS estimates in 8 quarters, and the stock still closed lower the next day 5 times. In 2 of the 5 where we have price data, the stock had already run up before the report.
- Aug 12, 2026EPS beat +8.3%stock -4.9% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
- May 13, 2026EPS beat +35.3%stock -0.4% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
- Mar 12, 2026EPS beat +16.7%stock -8.4% next day
- It had risen 41.5% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 6.2% higher, but sellers took over and it closed -8.4%.
- Nov 13, 2025EPS beat +15.8%stock -17.4% next day
- It opened 5.9% lower as soon as trading resumed.
- Mar 14, 2024EPS beat +13.2%stock -7.2% next day
- It had risen 9.7% in the 20 trading sessions before the report, so good news may already have been priced in.
Rose despite an EPS miss (1 of 2)
- Aug 14, 2025EPS missed -2.7%stock +2.2% next day
- It had already fallen 5.2% in the 20 trading sessions before the report, so weak results may have been expected.
- It opened 4.2% higher as soon as trading resumed.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was IPSC's earnings move already priced in?
IPSC's move in the month before each of its last 12 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 12 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does IPSC hold its opening gap after earnings?
IPSC's opening move after each report and where it closed that day.
In 5 reports IPSC opened at least 1% away from the previous close. It gave back half or more of that gap by the close 1 of 5 times (20%), and fully reversed 1 time. Gaps up faded 1 of 3; gaps down recovered 0 of 2.
- Mar 12, 2026ReversedOpened +6.2%, closed -8.4%
- Nov 13, 2025HeldOpened -5.9%, closed -17.4%
- Aug 14, 2025HeldOpened +4.2%, closed +2.2%
- Mar 19, 2025HeldOpened -1.5%, closed -5.7%
- Aug 8, 2024HeldOpened +4.0%, closed +4.0%
What the history says
- It fell after 5 of its 8 EPS beats (63%): beating estimates has not been enough on its own.
IPSC earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | Before open | -$0.11 | -$0.11 | 0.0% | -6.32% | — |
| Aug 12, 2026 | Before open | -$0.12 | -$0.11 | +8.3% | -4.85% | -6.80% |
| May 13, 2026 | Before open | -$0.17 | -$0.11 | +35.3% | -0.44% | +2.18% |
| Mar 12, 2026 | Before open | -$0.30 | -$0.25 | +16.7% | -8.42% | -10.99% |
| Nov 13, 2025 | Before open | -$0.38 | -$0.32 | +15.8% | -17.41% | -14.74% |
| Aug 14, 2025 | After close | -$0.37 | -$0.38 | -2.7% | +2.18% | 0.00% |
| May 15, 2025 | After close | $0.06 | $0.89 | +1383.3% | +8.32% | +16.05% |
| Mar 19, 2025 | After close | -$0.20 | -$0.43 | -115.0% | -5.66% | +0.17% |
| Nov 5, 2024 | Before open | -$0.45 | -$0.37 | +17.8% | +5.56% | +15.87% |
| Aug 8, 2024 | Before open | -$0.50 | -$0.38 | +24.0% | +4.05% | -4.05% |
| May 9, 2024 | Before open | -$0.45 | -$0.45 | 0.0% | -0.98% | -2.28% |
| Mar 14, 2024 | Before open | -$0.53 | -$0.46 | +13.2% | -7.20% | -2.26% |
IPSC Earnings FAQ
Answers computed from Century Therapeutics, Inc.'s reported history
IPSC has no upcoming report date in the calendar yet. It last reported on Nov 12, 2026; companies usually report every three months.
Over the last 12 quarters with a usable EPS surprise, IPSC beat the consensus estimate 8 times (67%), missed 2 and landed in line 2.
Across its last 12 quarters with a measured reaction, IPSC moved an average of ±6.0% in the first session after reporting. It closed higher 33% of the time; the largest gain was 8.3% and the largest drop -17.4%.
IPSC fell in the first session after 5 of its last 8 EPS beats (63%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 2 of the 5 of those falls where price data is available, the stock had already risen before the report.
Across its last 12 quarters with price data, IPSC moved an average of -1.3% in the 20 trading sessions before reporting and was higher in 33% of them. After a run-up of 3% or more (4 quarters), it fell the next day 75% of the time, averaging -3.4%. After a drop of 3% or more (7 quarters), it rose the next day 43% of the time, averaging 0.0%. This describes past reports; it is not a forecast.
In 5 reports IPSC opened at least 1% away from the previous close. It gave back half or more of that gap by the close 1 of 5 times (20%), and fully reversed once. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · IPSC: 12 reported quarters, latest Nov 12, 2026. Information only, not investment advice.
Looking for more on IPSC?
Price charts, forecast, fundamentals and risk pages for IPSC are not on Tickzen yet. You can run a full stock analysis now.
Run the IPSC Stock AnalyzerLatest TickZen Insights
AbbVie (ABBV) Q3 2026 Earnings Preview: Will Skyrizi and Rinvoq be able to justify the 20x?By Vishal Jadaun
Alphabet (GOOG) Q3 2026 Earnings Preview: Will Cloud Overtake Capex?By Vishal Jadaun
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun